PDF

Cigna Health & Life Insurance Company
Exhibit 3 • Cigna Exhibit 3 UM-20 Network Adequacy Provision (NAP)

Cigna Health & Life Insurance Act 152 Exhibit 3 • PS-8 Measuring Availability of Practitioners and Providers

Cigna Exhibit 3 • PS-6 Measuring Accessibility of Medical Service

Act 152 • MVP Health Annual Report

Act 152 Report • Cigna Life & Health Insurance Company (contents)
VT Rule H-2009-03 Checklist
Exhibit 1 - Attestation
Exhibit 2 - Geo Access
Exhibit 3
> PS-6 Measuring Accessibility of Medical Service
> PS-8 Measuring Availability of Practitioners and Providers
> UM-20 Network Adequacy Provision (NAP)
Exhibit 4 - Opportunities for Improvement
Exhibit 5 - NCQA Accreditation Certificate
Exhibit 6 - Vermont List of Specialty Drugs Acquired through Specialty Vendor 2024

Act 152 Report • Blue Cross and Blue Shield of Vermont

The report represents the captive insurance company data for all 2023 licensed captives combined. This information was compiled from the fiscal year-end 2023 annual statement financial reporting of each captive. Please note that this data does not represent audited information.

The Department of Financial Regulation has made available the NQTL Comparative Analysis Template for use by health insurance issuers on an annual basis. The exercise is for insurers to self-identify, correct identified issues and provide the Department a window into the processes in place if a practice is questioned.

Issuers are required to submit the NQTL template on an annual basis to the Department of Financial Regulation by July 1, 2024.